HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $120 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Compass Pathways (NASDAQ:CMPS) and maintained a $120 price target, as stated by analyst Patrick Trucchio.
July 31, 2024 | 12:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Compass Pathways and maintained a $120 price target, indicating strong confidence in the company's future performance.
The reiteration of a Buy rating and a high price target by a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100